Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Pharmacology in Drug Development|August 30, 2024
Meta-Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib ExposureLuke Fostvedt, Jian Liu, Xiaoxing Wang, et al.The AAPS Journal|March 18, 2018
PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting WorkflowChristian Hove Rasmussen, Mike K Smith, Kaori Ito, et al.Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.Clinical Pharmacology and Therapeutics|January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open DataDaniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.Clinical Pharmacokinetics|June 13, 2026
Elranatamab Population Pharmacokinetics and Exposure-Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple MyelomaJennifer E Hibma, Donald Irby, Alan Liu, et al.Clinical and Translational Science|July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisDaniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.Clinical and Translational Science|February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseKlaus Romero, Daniela Conrado, Jackson Burton, et al.Clinical Pharmacology and Therapeutics|September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative DiseasesDiane Stephenson, Enrique Aviles, Lisa J Bain, et al.Pageof 5